# Bankhaus Wölbern

> Bankhaus Wölbern is a VC fund in Hamburg backing Industrial, Biotechnology and Biomass Energy. See 1 investment, round sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Hamburg, Germany
- Total investments: 1
- Last investment: Oct 2007
- Lead investor: 0%
- Last updated: Aug 2026
- Website: http://www.woelbern.de

Bankhaus Wölbern is a provider of financial advisory services. The company offers private banking and investment advisory services.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Industrial | 1 | 100% |
| Biotechnology | 1 | 100% |
| Biomass Energy | 1 | 100% |

## Investments

| Company | Description | Round size | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| DIREVO Industrial Biotechnology | DIREVO provides customized solutions for various industries via the development and optimization of biocatalysts with its proprietary ultra-high-throughput screening platform. Serving the Feed & Food industries and chemical / biorefinery businesses, DIREVO products are developed either independently or in conjunction with global leaderssuch as Genencor (a division of Danisco A/S), AB Enzymes, Roal Ltd. and Nestlé. DIREVO Industrial Biotechnology GmbH is privately owned and located in Cologne, Germany. The shareholders include Wölbern EquityPartner GmbH (Hamburg), NRW Bank (Düsseldorf), TVM Capital (Munich), Danisco A/S (Copenhagen), a private equity firm affiliated with Sparkasse KölnBonn (Cologne), SandersMorrisHarris EnzymesLLC (New York), Mulligan BioCapital (Hamburg), and several private investors. | $16.8M | Series C | Oct 18, 2007 |  |

1 of 1 investments shown.

## Co-investors
- Danisco A/S — VC Fund, 1 deal together
- [Mulligan BioCapital](https://shizune.co/investors/profile/mulligan-biocapital) — VC Fund, 1 deal together
- [NRW.BANK](https://shizune.co/investors/profile/nrw-bank) — VC Fund, 1 deal together
- S-Equity Partner — VC Fund, 1 deal together
- [Signet Healthcare Partners](https://shizune.co/investors/profile/signet-healthcare-partners) — VC Fund, 1 deal together
- [TVM Capital](https://shizune.co/investors/profile/tvm-capital) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Sequoia Capital](https://shizune.co/investors/profile/sequoia-capital) — VC Fund
- [New Enterprise Associates](https://shizune.co/investors/profile/new-enterprise-associates) — VC Fund
- [Bessemer Venture Partners](https://shizune.co/investors/profile/bessemer-venture-partners) — VC Fund

## FAQ

### What does Bankhaus Wölbern invest in?

Bankhaus Wölbern invests primarily in Industrial, Biotechnology and Biomass Energy startups, most often at Series C stage. Most of the 1 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Bankhaus Wölbern last invest?

The most recent investment recorded for Bankhaus Wölbern closed in Oct 2007. Shizune tracks 1 investment in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co